Treatments for Rare hypoparathyroidism

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing data

FDA-approved treatments (2)

Patient support programs (3)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

Natpara

Takeda Pharmaceuticals U.S.A., Inc.

Verified 26d ago
copay card
copay assistancePatient Assistance
Accepting applications
Apply

Yorvipath

Ascendis

Hypoparathyroidism

Verified 25d ago
copay card
Copay CardPatient Assistance
Accepting applications
Copay Card Apply

NATPARA (parathyroid hormone)

Takeda

Hypoparathyroidism

Verified 25d ago
copay card
Copay CardPatient Assistance
Accepting applications
Apply

More about Rare hypoparathyroidism